ASCO: Afinitor Quells Herceptin Resistance

CHICAGO (MedPage Today) -- A study presented here may help unravel the issue of resistance to trastuzumab (Herceptin), a drug that is central to the treatment of HER2-positive breast cancer.
Source: MedPage Today OB/GYN - Category: OBGYN Source Type: news